A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
Peptides, composed of small chains of amino acids, represent a promising frontier in scientific research. Often regarded as intermediate molecules between proteins and amino acids, these compounds ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark – Zealand ...
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
Total gross proceeds from upsized initial public offering and Series C financing were approximately $251.2 millionLast subject last visit in ...
Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting ...
We spoke to David Craik to learn more about cyclotides, how they can be sustainably produced and their potential in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback